Ananda Ghosh
Stock Analyst at H.C. Wainwright
(3.69)
# 1,676
Out of 5,014 analysts
125
Total ratings
33.6%
Success rate
8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Reiterated: Buy | $12 → $8 | $1.66 | +381.93% | 11 | Oct 1, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $50 → $32 | $16.11 | +98.63% | 11 | Sep 30, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $37 → $33 | $20.15 | +63.77% | 15 | Sep 25, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $110 | $27.18 | +304.71% | 21 | Sep 22, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $7 | $1.18 | +493.22% | 1 | Sep 17, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $70 | $31.27 | +123.86% | 21 | Sep 9, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $2.42 | +726.45% | 14 | Sep 9, 2026 | |
| ANNX Annexon | Reiterated: Buy | $14 | $4.23 | +230.97% | 9 | Aug 14, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $50 | $26.00 | +92.31% | 11 | Aug 4, 2026 | |
| SKYE Skye Bioscience | Reiterated: Buy | $160 | $1.61 | +9,837.89% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $3.69 | +550.41% | 4 | Jan 28, 2026 |
ProQR Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $12 → $8
Current: $1.66
Upside: +381.93%
Dyne Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $50 → $32
Current: $16.11
Upside: +98.63%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $20.15
Upside: +63.77%
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $110
Current: $27.18
Upside: +304.71%
iBio, Inc.
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $1.18
Upside: +493.22%
Structure Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $70
Current: $31.27
Upside: +123.86%
PepGen
Sep 9, 2026
Reiterated: Buy
Price Target: $20
Current: $2.42
Upside: +726.45%
Annexon
Aug 14, 2026
Reiterated: Buy
Price Target: $14
Current: $4.23
Upside: +230.97%
Stoke Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $50
Current: $26.00
Upside: +92.31%
Skye Bioscience
May 21, 2026
Reiterated: Buy
Price Target: $160
Current: $1.61
Upside: +9,837.89%
Jan 28, 2026
Reiterated: Buy
Price Target: $24
Current: $3.69
Upside: +550.41%